Melatonin 15 mg by tnvitamins — Ingredients, Evidence & Safety

Product Label

📄 Open Full PDF View on NIH DSLD →

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Safety Alerts

⚠️ Melatonin: 15mg is 1.5× the Tolerable Upper Intake Level (10mg)

The safety score is low because the 15mg dose of melatonin exceeds the recommended maximum daily intake of 10mg.

Label Data

1 Capsule(s) Serving Size

240 Servings

Non-Nutrient/Non-Botanical Product Type

100% Evidence Coverage

Supplement Facts — Evidence Check

Melatonin

15 mg

⚠️ Exceeds Tolerable Upper Intake Level by 1.5× (UL: 10 mg) 📚 236 studies (Tier A: 2, B: 109)

This product: 15mg UL 10mg

Other Ingredients

Gelatin Rice powder Vegetable Magnesium Stearate Silica

Label Claims — Verification

❓ All Other

All Other (100% of products) Structure/Function (86% of products) Nutrient (7% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Directions: For adults, take one (1) capsule 30 minutes before bedtime as melatonin may cause drowsiness. Do not exceed recommended dose of one (1) capsule daily.

⚠️ Warnings & Precautions

Do not exceed recommended dose of one (1) capsule daily.

Caution: Do not take if you are pregnant or lactating, an individual with an auto-immune condition or a depressive disorders, or if you are under 18 years of age.

If you are under medical supervision, please consult a doctor before use. Discontinue use and consult a doctor if any adverse reactions occur. When using this product do not consume alcohol, operate machinery, or drive a motor vehicle.

Keep out of reach of children.

🧪 Formulation Notes

Extra strength

Melatonin 15 mg per capsule

Additional Information

Store in a cool, dry place.

New

8 month supply

Product Details

DSLD Entry Date 2024-07-25

Product Type Non-Nutrient/Non-Botanical

Form Capsule

Brand tnvitamins

DSLD ID 314545

Data Updated 2026-04-11

Research Evidence

291 Research Sources

55 Avg Quality Score

129 Meta Analysis

93 Systematic Review

51 Rct

11 Clinical Trial

2 Other

2 Regulatory Source

1 Openfda Safety

A Interventions for preventing delirium in hospitalised non-ICU patients

Meta Analysis The Cochrane database of systematic reviews 2016

PubMed DOI

A Melatonin for preoperative and postoperative anxiety in adults

Meta Analysis The Cochrane database of systematic reviews 2020

PubMed DOI Cochrane

A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials

Meta Analysis BMJ open 2022

PubMed DOI

B Pharmacological interventions for prevention of weight gain in people with schizophrenia

Meta Analysis The Cochrane database of systematic reviews 2022

PubMed DOI

B Melatonin for pre- and postoperative anxiety in adults

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI Cochrane

B Prevention of depression in adults with long-term physical conditions

Meta Analysis The Cochrane database of systematic reviews 2021

PubMed DOI

B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis

Systematic Review Lancet (London, England) 2022

PubMed DOI

B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis

Meta Analysis BMJ open 2023

PubMed DOI

B Second-generation antidepressants for preventing seasonal affective disorder in adults

Meta Analysis The Cochrane database of systematic reviews 2015

PubMed DOI

B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries

Meta Analysis The Cochrane database of systematic reviews 2021

PubMed DOI

View all evidence for Melatonin →